Health

Broadening Access to COVID-19 Drugs

Broadening Access to COVID-19 Drugs

Regulators should expand the types of medical professionals who can prescribe COVID-19 drugs.

The AI Health Care Dilemma

The AI Health Care Dilemma

Scholars explore regulatory approaches to artificial intelligence in the health care sector.

Negotiating Prices with Drug Manufacturers

Negotiating Prices with Drug Manufacturers

The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States.

How Factory Farming Could Cause the Next COVID-19

How Factory Farming Could Cause the Next COVID-19

The CDC should recommend agricultural reforms to reduce pandemic risks caused by factory farms.

Toxic Metals in Baby Food Remain Unregulated

Toxic Metals in Baby Food Remain Unregulated

Despite delayed government action, manufacturers can do more to reduce toxic metals in baby food.

Telehealth Abortion Care

Telehealth Abortion Care

Scholars consider how the authorization of telehealth can expand access to medication abortion.

Are Food Regulators Stepping up to the Plate?

Are Food Regulators Stepping up to the Plate?

In this week’s Saturday Seminar, we collect scholarship discussing quality and safety issues within U.S. food regulation.

Hallucinate, Medicate, and Regulate

Hallucinate, Medicate, and Regulate

In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.

Nonprofit Hospital Standards Under Fire

Nonprofit Hospital Standards Under Fire

Research shows that nonprofit hospitals may not be fulfilling the obligations of their tax-exempt status

Using Insurance to Regulate Food Safety

Using Insurance to Regulate Food Safety

Insurance underwriters can help farmers manage the risk of microbial contamination in their fields.

Reforming Accountable Care Organizations

Reforming Accountable Care Organizations

Experts explore opportunities to reduce costs and promote health equity.

Cancer Moonshot Lands with FDA

Cancer Moonshot Lands with FDA

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.